JH
Jeffrey Hung Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
50
Avg Return
Past Year
Past Year
14%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $205 |
23%
upside
| 3 | +3% |
0
%
| 17 Nov ‘25 17 days ago |
|
|
|
Overweight
Maintained
| $19 |
132%
upside
| 2 | +18% |
0
%
| 12 Nov ‘25 22 days ago |
|
|
|
Overweight
Maintained
| $173 |
13%
upside
| 3 | +1.1% |
0
%
| 11 Nov ‘25 23 days ago |
|
|
|
Overweight
Maintained
| $129 |
22%
upside
| 2 | +23% |
0
%
| 16 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $77 |
62%
upside
| 1 | +3.5% |
0
%
| 29 Sep ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $79 |
76%
upside
| 1 | +15% |
0
%
| 17 Sep ‘25 2 months ago |
|